Trials / Recruiting
RecruitingNCT04085029
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.
Conditions
Timeline
- Start date
- 2019-09-26
- Primary completion
- 2029-09-01
- Completion
- 2029-09-01
- First posted
- 2019-09-11
- Last updated
- 2026-02-05
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04085029. Inclusion in this directory is not an endorsement.